NHM - NRHM & NUHM

•Download as PPTX, PDF•

16 likes•344 views

The document discusses major milestones but provides no details about specific milestones or events. It consists entirely of blank lines with no substantive information. In 3 sentences or less, this document cannot be meaningfully summarized due to the lack of any informative content.

Health & Medicine

What's hot

What is a Wellness Center?

typicaldisease886

Health planning in india

Dr Lipilekha Patnaik

National Rural Health Mission (NRHM) India

Kailash Nagar

Primary health care

pramod kumar

International health agencies

Jobin Jacob

Cphc hwc

ANMTC, KATIHAR

Health Subcentre evaluationRizwan S A

Health care delivery system (2)Rajeswari Muppidi

Health care delivery system in India - community Health Nursing

KULDEEP VYAS

Concpt & levels of prevention

Dr Shubhangi (Kshirsagar) Hedau

Health care Delivery system

Princess Pearl

National health policy 2017.pptx

Dr. Chirag Sonkusare

Fulll chapter of national diarroheal control programme in nepal

MonikaRijal1

Home Visiting.ppt

VeereshDemashetti

Primary health care copychettinad college of nursing

Nursing Management .ppt

DelphyVarghese

National neonatal strategy

Chetkant Bhusal

Presentation on Ayushman bharat Yojana by PM Modi

Vibhansh

Five year plans anand

Anand Gowda

Terms used in mental health nursing

Jasleen Kaur

What's hot (20)

What is a Wellness Center?

Health planning in india

National Rural Health Mission (NRHM) India

Primary health care

International health agencies

Cphc hwc

Health Subcentre evaluation

Health care delivery system (2)

Health care delivery system in India - community Health Nursing

Concpt & levels of prevention

Health care Delivery system

National health policy 2017.pptx

Fulll chapter of national diarroheal control programme in nepal

Home Visiting.ppt

Primary health care copy

Nursing Management .ppt

National neonatal strategy

Presentation on Ayushman bharat Yojana by PM Modi

Five year plans anand

Terms used in mental health nursing

Recently uploaded

Evaluation of antidepressant activity of clitoris ternatea in animals

Shweta

Prix Galien International 2024 Forum Program

Levi Shapiro

June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels: - ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING - WOMEN’S HEALTH: FERTILITY PRESERVATION - WHAT’S NEW IN THE TREATMENT OF INFECTIOUS, ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES? - ARTIFICIAL INTELLIGENCE AND ETHICS - GENE THERAPY - BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE - ETHICAL CHALLENGES IN LIFE SCIENCES - Prix Galien International Awards Ceremony

Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...

Savita Shen $i11

Ocular injury ppt Upendra pal optometrist upums saifai etawah

pal078100

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf

Anujkumaranit

Surgical Site Infections, pathophysiology, and prevention.pptx

jval Landero

Physiology of Chemical Sensation of smell.pdf

MedicoseAcademics

Title: Sense of Smell Presenter: Dr. Faiza, Assistant Professor of Physiology Qualifications: MBBS (Best Graduate, AIMC Lahore) FCPS Physiology ICMT, CHPE, DHPE (STMU) MPH (GC University, Faisalabad) MBA (Virtual University of Pakistan) Learning Objectives: Describe the primary categories of smells and the concept of odor blindness. Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction. Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain. Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential. Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes. Key Topics: Olfactory Genes: 3% of the human genome accounts for olfactory genes. 400 genes for odorant receptors. Olfactory Membrane: Located in the superior part of the nasal cavity. Medially: Folds downward along the superior septum. Laterally: Folds over the superior turbinate and upper surface of the middle turbinate. Total surface area: 5-10 square centimeters. Olfactory Mucosa: Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell. Sustentacular Cells: Produce mucus and maintain ionic and molecular environment. Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months. Bowman’s Gland: Secretes mucus. Stimulation of Olfactory Cells: Odorant dissolves in mucus and attaches to receptors on olfactory cilia. Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve. Quality of a Good Odorant: Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble. Facilitated by odorant-binding proteins in mucus. Membrane Potential and Action Potential: Resting membrane potential: -55mV. Action potential frequency in the olfactory nerve increases with odorant strength. Adaptation Towards the Sense of Smell: Rapid adaptation within the first second, with further slow adaptation. Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system. Primary Sensations of Smell: Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid. Odor Detection Threshold: Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm). Some toxic substances are odorless at lethal concentrations. Characteristics of Smell: Odor blindness for single substances due to lack of appropriate receptor protein. Behavioral and emotional influences of smell. Transmission of Olfactory Signals: From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition. Primitive, less old, and new olfactory systems with different path

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

i3 Health

i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource. This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and Associate Division Director for Ambulatory Operations The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma. STATEMENT OF NEED Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL. Target Audience Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL). Learning Objectives 1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL 2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults 3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection

ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS

Dr. Vinay Pareek

Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx

Dr. Rabia Inam Gandapore

The Normal Electrocardiogram - Part I of II

MedicoseAcademics

These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram. Learning objectives: 1. Define an electrocardiogram (ECG) and electrocardiography 2. Describe how dipoles generated by the heart produce the waveforms of the ECG 3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II) 4. Differentiate between intervals and segments 5. Enlist some common indications for obtaining an ECG Study Resources: 1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition 2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition 3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition 4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/ 5. ECG in Medical Practice by ABM Abdullah, 4th edition 6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics

For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls

Savita Shen $i11

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

Oleg Kshivets

RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0). CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.

The hemodynamic and autonomic determinants of elevated blood pressure in obes...

Catherine Liao

basicmodesofventilation2022-220313203758.pdf

aljamhori teaching hospital

KDIGO 2024 guidelines for diabetologists

د.محمود نجيب

Superficial & Deep Fascia of the NECK.pptx

Dr. Rabia Inam Gandapore

ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx

Swetaba Besh

POST OPERATIVE OLIGURIA and its management

touseefaziz1

Couples presenting to the infertility clinic- Do they really have infertility...

Sujoy Dasgupta

Recently uploaded (20)

Evaluation of antidepressant activity of clitoris ternatea in animals

Prix Galien International 2024 Forum Program

Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...

Ocular injury ppt Upendra pal optometrist upums saifai etawah

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf

Surgical Site Infections, pathophysiology, and prevention.pptx

Physiology of Chemical Sensation of smell.pdf

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS

Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx

The Normal Electrocardiogram - Part I of II

For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

The hemodynamic and autonomic determinants of elevated blood pressure in obes...

basicmodesofventilation2022-220313203758.pdf

KDIGO 2024 guidelines for diabetologists

Superficial & Deep Fascia of the NECK.pptx

ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx

POST OPERATIVE OLIGURIA and its management

Couples presenting to the infertility clinic- Do they really have infertility...

NHM - NRHM & NUHM

10.

11.

12.

13.

14. The major milestones so far include

NHM - NRHM & NUHM

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

More from Jobin Jacob

More from Jobin Jacob (20)

Recently uploaded

Recently uploaded (20)

NHM - NRHM & NUHM